• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Topical Calcineurin Inhibitors: Abstract Reference Information

Additional Reference information:


Abstract: “Changes in Topical Calcineurin Use Following Regulatory Action in the US.”

David Money, R.Ph., Lois La Grenade, M.D., M.P.H., and Allen Brinker, M.D., M.S.

U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD.